https://www.selleckchem.com/pr....oducts/2-deoxy-d-glu
Cumulative mortality increased with progressive renal dysfunction (normal/stage 1 0.0%, stage 2 3.6%, stage 3 12.1%, and stage 4 32.3%, log rank p0.001). A 10ml/min/1.73m incremental decrease in eGFR was associated with an adjusted HR for mortality of 1.43 (95% CI 1.20-1.72, p0.001). Renal impairment was associated with mortality in patients presenting with elevated cardiac troponin and non-obstructive coronary arteries. Hence, renal function should be incorporated into the risk stratification of these patients. Renal
Like
Comment
Share
